Patients receiving dapagliflozin showed placebo-subtracted increases in total , LDL , and HDL cholesterol ( @ mg/dL , P = @ ; @ mg/dL , P = @ ; @ mg/dL , P = @ , respectively ) with no change in LDL/HDL cholesterol ratio ( @ ; P = @ ) or triglycerides ( -@ mg/dL ; P = @ ) .